Michael Cameron, MD, FAAD

Michael Cameron, MD, FAAD, is chief executive officer of Equity Medical, LLC; president of Cameron Dermatology, PLLC; and assistant clinical professor in the Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York City.

Dr Cameron completed his residency training at Memorial Sloan Kettering Cancer Center and the University of Colorado. Prior to residency training, he received his undergraduate degree from Duke University and his medical degree from the University of South Florida.

He is a board-certified dermatologist with expertise in drug development and inflammatory skin disease. He has previous work experience in the pharmaceutical industry, health care consulting, and academic medicine. He is a regular consultant for biotech and pharmaceutical companies, as well as sell-side and buy-side biopharma stakeholders.

Previously serving as medical director at Pfizer, Dr Cameron prides himself on remaining up to date on the latest treatment options for his patients. He has expertise in treating eczema, psoriasis, alopecia areata and other forms of hair loss, hidradenitis suppurativa, vitiligo, acne, and skin cancer, as well as in performing various cosmetic treatments, including onabotulinumtoxinA, fillers, threads, lasers, liposuction, radiofrequency microneedling, platelet-rich plasma, and chemical peels. He is coauthor of more than 20 publications in peer-reviewed medical journals and 2 dermatology textbook chapters. He has presented his research at various medical conferences.

Equity Medical is a multistate, multispecialty clinical research center with locations in New York, NY, and Bowling Green, KY. Cameron Dermatology is a comprehensive, state-of-the-art dermatology practice on the Upper West Side of Manhattan.